Holen Sie sich die Stockscreener-App
169.70
1.20%
-1.92
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt EFX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$171.62
Offen:
$170.17
24-Stunden-Volumen:
153.50K
Relative Volume:
0.10
Marktkapitalisierung:
$19.94B
Einnahmen:
$6.28B
Nettoeinkommen (Verlust:
$703.80M
KGV:
29.89
EPS:
5.6784
Netto-Cashflow:
$1.14B
1W Leistung:
-8.58%
1M Leistung:
-7.12%
6M Leistung:
-17.13%
1J Leistung:
-32.72%
1-Tages-Spanne:
$166.65
$170.26
1-Wochen-Bereich:
$166.65
$192.51
52-Wochen-Spanne:
$150.75
$271.84
Equifax Inc Stock (EFX) Company Profile
Firmenname
Equifax Inc
Sektor
Branche
Telefon
(404) 885-8000
Adresse
1550 PEACHTREE ST NW, ATLANTA, GA
Compare EFX vs VRSK, BAH, FCN, HURN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EFX
Equifax Inc
|
169.70 | 20.16B | 6.28B | 703.80M | 1.14B | 5.6784 |
VRSK
Verisk Analytics Inc
|
176.06 | 22.84B | 3.10B | 910.20M | 1.13B | 6.5659 |
BAH
Booz Allen Hamilton Holding Corp
|
72.55 | 8.67B | 11.22B | 845.00M | 951.00M | 6.8984 |
FCN
Fti Consulting Inc
|
150.12 | 4.17B | 3.87B | 266.68M | 255.97M | 8.4148 |
HURN
Huron Consulting Group Inc
|
146.86 | 2.35B | 1.75B | 103.75M | 103.64M | 5.8551 |
Equifax Inc Stock (EFX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-16 | Eingeleitet | Mizuho | Outperform |
| 2026-02-17 | Fortgesetzt | BofA Securities | Buy |
| 2025-10-13 | Eingeleitet | Oppenheimer | Outperform |
| 2025-10-01 | Eingeleitet | Seaport Research Partners | Neutral |
| 2025-07-10 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-06-23 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-04-10 | Fortgesetzt | BofA Securities | Buy |
| 2025-04-04 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2025-03-20 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-03-14 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2025-02-11 | Herabstufung | Argus | Buy → Hold |
| 2024-12-16 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2024-12-12 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-12-12 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-10-01 | Eingeleitet | UBS | Buy |
| 2024-09-19 | Hochstufung | Exane BNP Paribas | Underperform → Neutral |
| 2024-08-13 | Eingeleitet | Wells Fargo | Overweight |
| 2024-07-09 | Eingeleitet | Wolfe Research | Outperform |
| 2024-02-13 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2024-01-11 | Herabstufung | Redburn Atlantic | Buy → Neutral |
| 2024-01-08 | Hochstufung | BofA Securities | Underperform → Buy |
| 2024-01-04 | Bestätigt | Needham | Buy |
| 2023-12-19 | Eingeleitet | Oppenheimer | Outperform |
| 2023-12-18 | Hochstufung | Jefferies | Hold → Buy |
| 2023-12-15 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-12-08 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2023-11-20 | Eingeleitet | Citigroup | Buy |
| 2023-07-24 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-01-06 | Eingeleitet | Exane BNP Paribas | Underperform |
| 2022-11-15 | Hochstufung | Atlantic Equities | Neutral → Overweight |
| 2022-10-21 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-10-19 | Herabstufung | Jefferies | Buy → Hold |
| 2022-08-16 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-15 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2022-07-13 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-04-21 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-03-30 | Eingeleitet | Deutsche Bank | Hold |
| 2022-03-11 | Fortgesetzt | BofA Securities | Neutral |
| 2022-01-31 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-01-27 | Hochstufung | Truist | Hold → Buy |
| 2022-01-24 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2022-01-05 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-11-22 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2021-10-22 | Hochstufung | Argus | Hold → Buy |
| 2021-10-15 | Fortgesetzt | Evercore ISI | Outperform |
| 2021-07-23 | Bestätigt | Goldman | Neutral |
| 2021-07-08 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2020-12-15 | Hochstufung | Atlantic Equities | Neutral → Overweight |
| 2020-12-11 | Hochstufung | Stifel | Hold → Buy |
| 2020-12-08 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-10-07 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2020-10-06 | Eingeleitet | Needham | Buy |
| 2020-07-10 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2020-06-09 | Herabstufung | SunTrust | Buy → Hold |
| 2020-05-15 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2020-04-06 | Herabstufung | Argus | Buy → Hold |
| 2020-03-13 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-03-02 | Hochstufung | Exane BNP Paribas | Underperform → Outperform |
| 2020-01-17 | Hochstufung | Argus | Hold → Buy |
| 2019-11-22 | Eingeleitet | Jefferies | Buy |
| 2019-03-15 | Eingeleitet | Exane BNP Paribas | Underperform |
| 2019-02-05 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2018-12-07 | Fortgesetzt | Credit Suisse | Outperform |
| 2018-10-26 | Bestätigt | Barclays | Equal Weight |
| 2018-10-23 | Fortgesetzt | BofA/Merrill | Underperform |
| 2018-04-10 | Eingeleitet | BofA/Merrill | Underperform |
| 2017-12-14 | Herabstufung | Barclays | Overweight → Equal Weight |
Alle ansehen
Equifax Inc Aktie (EFX) Neueste Nachrichten
Equifax Inc (EFX) Stock Down 3.1% -- Now Undervalued? GF Score: 75/100 - GuruFocus
Equifax Inc. stock outperforms competitors despite losses on the day - MarketWatch
Equifax EVP, CFO & COO John W Jr. Gamble sells $845,820 in stock - Investing.com India
(EFX) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
BNP Paribas Upgrades Equifax to Outperform From Neutral, Adjusts PT to $245 From $190 - marketscreener.com
Analyst recommendations: Amgen, Equifax, Lockheed Martin, Phillips 66, Valero Energy… - marketscreener.com
Equifax Inc. stock falls after regulator move hits credit scoring peers - AD HOC NEWS
Quality Investing Standout: Equifax (NYSE:EFX) Clears the Hurdles - ChartMill
Equifax Inc. stock holds steady as investors watch credit data trends - AD HOC NEWS
Analysts Offer Insights on Industrial Goods Companies: Equifax (EFX) and RXO, Inc. (RXO) - The Globe and Mail
Equifax (EFX) Faces Complaint Portal Focus, Is It A Bargain? - Yahoo Finance
Equifax Stock Price Forecast. Should You Buy EFX? - StockInvest.us
Equifax Inc (EFX) Stock Down 6.4% -- Now Undervalued? GF Score: 75/100 - GuruFocus
Financials Down on Rate Hike ExpectationsFinancials Roundup - marketscreener.com
Equifax shares tumble more than 6% after heightened scrutiny from Federal Housing Finance Agency - Traders Union
FICO Plunges 21%, Credit Bureaus Fall, as Pulte Renews Criticism - Bloomberg.com
FICO Stock Plunges as FHFA Pushes VantageScore and Threatens Credit Bureau Model - Barron's
Fair Isaac, Equifax, TransUnion Shares Fall After FHFA Director Bill Pulte's Criticism on Credit Bureaus - marketscreener.com
Equifax Inc Stock (EFX) Moved Down by 7.02% on Sep 4: Facts Behind the Movement - tradingkey.com
Credit Bureau, Fair Isaac Shares Retreat as FHFA Chief Pulte Slams Industry -- Update - marketscreener.com
FHFA Criticizes FICO; Credit Bureaus Stocks Slide - Briefs Finance
Equifax Inc. (EFX) Peer Comparison – Compare with Others - Value Research
Equifax Stock Slides Friday: What's Happening? - Benzinga
Equifax Slides as Mortgage Credit Score Competition Clouds Outlook - Quiver Quantitative
Equifax Down Over 8%, on Pace for Largest Percent Decrease Since February -- Data Talk - moomoo.com
Goldman Sachs Maintains Equifax(EFX.US) With Hold Rating, Raises Target Price to $199 - Moomoo
EFX Looks 35.2% Undervalued on GF Value™ - GuruFocus
Goldman Sachs Adjusts Price Target on Equifax to $199 From $182, Keeps Neutral Rating - Moomoo
FICO, Equifax and TransUnion stocks fall on credit scoring shift - Investing.com
FICO, Equifax and TransUnion stocks fall on credit scoring shift By Investing.com - Investing.com UK
Equifax Inc. stock gains as US housing chief backs VantageScore and criticizes credit agencies - AD HOC NEWS
US directs Fannie Mae, Freddie Mac to approve VantageScore for all lenders - marketscreener.com
Pulte accuses Equifax, Experian, TransUnion of overcharging Americans By Investing.com - Investing.com Australia
Credit reporting reforms coming for Equifax and others, Bill Pulte states - Traders Union
Equifax Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
September 2026 Class Action Settlements Involve Disney, Tesla and Equifax - Yahoo Finance
Equifax : July 2026 U.S. National Consumer Credit Trends Report - marketscreener.com
$2.2M Equifax credit reporting class action settlement - Top Class Actions
EFX Gains From Data Advantage & Innovations Amid Refinancing Risks - TradingView
Equifax Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Equifax Class Action: Last Day to Claim Part of the $2.2M Settlement - CNET
Equifax Inc. stock underperforms Monday when compared to competitors - MarketWatch
Equifax Inc's Dividend Analysis - Yahoo Finance
Did Equifax's (EFX) Dividend Steadiness and Legal Settlement Proposal Just Reframe Its Risk‑Reward Profile? - simplywall.st
Equifax (EFX) Stock Looks Fully Valued After $100 Million Settlement - Yahoo Finance
Equifax Inc. stock outperforms competitors on strong trading day - MarketWatch
Be Sure To Check Out Equifax Inc. (NYSE:EFX) Before It Goes Ex-Dividend - Sahm
Equifax gets preliminary approval for $100M FCRA settlement - eciks.org
This Equifax Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday - Benzinga
Equifax upgraded to 'Buy' with 22% upside after strong Q2 results and undervaluation. - Pluang
Equifax stock gains on a rating upgrade and Q2 2026 beat - Ad-hoc-news.de
Finanzdaten der Equifax Inc-Aktie (EFX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.98%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):